|
24 October 2006
Sudden unexpected death in epilepsy (SUDEP)
accounts for about 500 deaths in the UK
every year. Post-mortem examinations typically
reveal no specific cause of death, but most
deaths are thought to occur because breathing
and heart function are compromised during
or as a result of a seizure. Breathing is
often affected during seizures and there
is some recent evidence that seizures can
on rare occasions cause a fatal interruption
to the normal functioning of the heart.
Although preventing seizures with treatment
is considered to be the best protection
against SUDEP, it's also known that anti-epileptic
medication can affect the electrical activity
of the heart. Further, there are certain
types of epilepsy caused by genetic alterations
to ion channels in cells; these alterations
affect both brain and heart tissue, so in
these cases, we might expect to see heart
abnormalities in addition to epilepsy, though
for the moment this is only a theory.
We know that people who died from SUDEP
tend to have several of the following features
of their condition:
- uncontrolled seizures (this is the most
important factor)
- young adults
- generalised tonic-clonic seizures
- learning disability
- found dead in bed, indicating seizures
during sleep
- unwitnessed seizures
- treatment factors, such as a history
of not complying with treatment, and frequent
changes of drug and dosage.
Studying people who have epilepsy with
these features may point to underlying clinical
conditions which might predispose them to
dying in a seizure.
Dr Sanjiv Petkar and colleagues from the
Manchester Royal Infirmary therefore investigated
heart function in 128 patients from the
David Lewis Centre in Cheshire. All patients
had severe epilepsy and learning difficulties,
and all had seizures that did not respond
to treatment with anti-epileptic drugs.
The researchers investigated heart function
in these patients by carrying out electrocardiograms
(ECGs).
An ECG measures the electrical activity
of the heart, including the rate and regularity
of the heartbeats. Carrying out an ECG involves
attaching a number of electrodes to the
arm, leg and chest of a seated patient.
The test is painless.
In their preliminary report, which they
presented at the World Congress of Cardiology
2006 in Barcelona, Spain, Dr Petkar and
his colleagues said that 60% of patients
in the study had some sort of abnormality
on their ECG. The majority of these abnormalities
were very mild, and none were severe enough
to disrupt normal heart function. However
this finding may be an indication that heart
problems of various kinds may be more common
in patients with this type of epilepsy.
This is interesting because overly-low and
overly-high heart rates are both preventable
with medication. Might a proportion of SUDEP
deaths be preventable?
Dr Petkar and his colleagues will now carry
out more studies on the same group of patients
to get more detailed information about the
types of heart abnormalities seen. They
will also study a group of people with epilepsy
living in the community and compare their
heart rhythms to those of the first group.
|